BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25440474)

  • 1. Circulating anti-Müllerian hormone levels in relation to nutritional status and selected adipokines levels in polycystic ovary syndrome.
    Olszanecka-Glinianowicz M; Madej P; Owczarek A; Chudek J; Skałba P
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):98-104. PubMed ID: 25440474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results.
    Yetim A; Yetim Ç; Baş F; Erol OB; Çığ G; Uçar A; Darendeliler F
    J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):288-97. PubMed ID: 27125339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Müllerian Hormone in Obese Adolescent Girls With Polycystic Ovary Syndrome.
    Kim JY; Tfayli H; Michaliszyn SF; Lee S; Nasr A; Arslanian S
    J Adolesc Health; 2017 Mar; 60(3):333-339. PubMed ID: 27998701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between Anti-Müllerian hormone and other reproductive parameters in normal women and in women with polycystic ovary syndrome.
    Koutlaki N; Dimitraki M; Zervoudis S; Poiana C; Psillaki A; Nikas I; Liberis A; Badiu C; Liberis V
    J Med Life; 2013 Jun; 6(2):146-50. PubMed ID: 23904873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMH as part of the diagnostic PCOS workup in large epidemiological studies.
    Piltonen TT; Komsi E; Morin-Papunen LC; Korhonen E; Franks S; Järvelin MR; Arffman RK; Ollila MM
    Eur J Endocrinol; 2023 Jun; 188(6):547-554. PubMed ID: 37294941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determining the age group-based cut-off values of serum anti-Mullerian hormone concentrations to diagnose polycystic ovary syndrome.
    Timur HT; Cimrin D; Gursoy Doruk O; Dogan OE
    Curr Med Res Opin; 2023 Jun; 39(6):855-863. PubMed ID: 37074782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of vit D and AMH and its correlation with polycystic ovarian parameters in obese and non-obese Egyptian women.
    Hegazy M; El-Mahdy HA; Elsayed TS; Elkhawaga SY; Elkady MA; Yehia AM; El-Husseiny AA; Shaban HM; Gomaa MH; Mokhtar MM
    Pathol Res Pract; 2023 Nov; 251():154872. PubMed ID: 37820441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum LH levels are associated to serum insulin and Anti-Müllerian hormone levels in women with both functional hypothalamic amenorrhoea and polycystic ovarian morphology.
    Makolle S; Catteau-Jonard S; Robin G; Dewailly D
    Clin Endocrinol (Oxf); 2023 Jul; 99(1):73-78. PubMed ID: 36912207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased body mass index is negatively associated with ovarian reserve as measured by anti-Müllerian hormone in patients with polycystic ovarian syndrome.
    Kloos J; Perez J; Weinerman R
    Clin Obes; 2024 Jun; 14(3):e12638. PubMed ID: 38156530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of elevated LH/FSH ratio in lean PCOS revisited: a path analysis.
    Pratama G; Wiweko B; Asmarinah ; Widyahening IS; Andraini T; Bayuaji H; Hestiantoro A
    Sci Rep; 2024 Apr; 14(1):8229. PubMed ID: 38589425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of lipid profile and obesity in patients with polycystic ovary syndrome.
    Parveen S; Khan S; Khan MM; Gupta B; Ahmad A; Alam R
    Endocr Regul; 2024 Jan; 58(1):83-90. PubMed ID: 38656255
    [No Abstract]   [Full Text] [Related]  

  • 12. Follicle Stimulating Hormone (LH: FSH) Ratio in Polycystic Ovary Syndrome (PCOS) - Obese vs. Non- Obese Women.
    Saadia Z
    Med Arch; 2020 Aug; 74(4):289-293. PubMed ID: 33041447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Association of Anti-Mullerian Hormone and Infertility Hormonal Imbalance with Polycystic Ovarian Syndrome Among Iraqi Patients.
    Taha RF; Al-Ouqaili MTS; Abdullah SA
    Pak J Biol Sci; 2023 Apr; 26(5):241-248. PubMed ID: 37859555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of bariatric surgery on ovarian reserve markers and its correlation with nutritional parameters and adipokines.
    Andreu A; Flores L; Méndez M; Ibarzabal A; Casals G; Mercadé I; Borrás A; Barral Y; Agustí I; Manau D; Vidal J; Casals G
    Front Endocrinol (Lausanne); 2024; 15():1284576. PubMed ID: 38559698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the clinical diagnostic value of anti-Müllerian hormone in polycystic ovarian syndrome and its correlation with clinical and metabolism indicators.
    Wang L; Luo M; Yu X; Li R; Ye F; Xiong D; Gong Y; Zheng M; Liu W; Zeng J
    J Ovarian Res; 2024 Apr; 17(1):78. PubMed ID: 38600539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between obesity and anti-Müllerian hormone in reproductive-aged African American women.
    Bernardi LA; Carnethon MR; de Chavez PJ; Ikhena DE; Neff LM; Baird DD; Marsh EE
    Obesity (Silver Spring); 2017 Jan; 25(1):229-235. PubMed ID: 27925445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between leptin, adiponectin levels and the ovarian reserve in women of reproductive age.
    Nikolettos K; Vlahos N; Pagonopoulou O; Nikolettos N; Zikopoulos K; Tsikouras P; Kontomanolis E; Damaskos C; Garmpis N; Psilopatis I; Asimakopoulos B
    Front Endocrinol (Lausanne); 2024; 15():1369248. PubMed ID: 38828407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between serum apelin, visfatin levels, and body composition in Polycystic Ovary Syndrome patients.
    Kuai D; Tang Q; Wang X; Yan Q; Tian W; Zhang H
    Eur J Obstet Gynecol Reprod Biol; 2024 Jun; 297():24-29. PubMed ID: 38555852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of dietary approaches to stop hypertension diet on weight loss, anti-Müllerian hormone and metabolic profiles in women with polycystic ovary syndrome: A randomized clinical trial.
    Foroozanfard F; Rafiei H; Samimi M; Gilasi HR; Gorjizadeh R; Heidar Z; Asemi Z
    Clin Endocrinol (Oxf); 2017 Jul; 87(1):51-58. PubMed ID: 28316072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin versus metformin plus pioglitazone on gonadal and metabolic profiles in normal-weight women with polycystic ovary syndrome: a single-center, open-labeled prospective randomized controlled trial.
    Zhao H; Zhang J; Xing C; Cheng X; He B
    J Ovarian Res; 2024 Feb; 17(1):42. PubMed ID: 38374053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.